Voyager Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview

Voyager Therapeutics

01/08/2023 19:37

* Voyager Therapeutics Inc  VYGR.OQ   VYGR.O  is expected
to show
a rise in quarterly revenue when it reports  results on August
3. 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 124.7% increase in revenue to $1.6 million from $712 thousand
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Voyager
Therapeutics Inc
is for a loss of 57 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 31.1%
in the last three months. ​
    * Wall Street's median 12-month price target for Voyager
Therapeutics Inc is $14.5​, above​ its last closing price
of $9.32. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  1.00        0.77       2.94      Beat    281
 Dec. 31 2023  -0.54       -0.55      -0.61     Missed  -11.5
 Sep. 30 2022  -0.31       -0.32      0.45      Beat    241.9​
 Jun. 30 2022  -0.48       -0.32      -0.50     Missed  -57.5
 ​​Mar.        -0.25       -0.34      -0.56     Missed  -62.7
 31 2022                                                
 Dec. 31 2021  -0.71       -0.32      0.15      Beat    147.4​
 Sep. 30 2021  -0.74       -0.73      -0.67     Beat    7.9
 Jun. 30 2021  -0.72       -0.71      -0.80     Missed  -12.3
 This summary was machine generated August 1 at 18:36 GMT.  All
figures in US dollars  unless otherwise stated